#	Pagina
attuale pagina	/open-h2020/projects/223617/index.html
-1	/open-h2020/projects/209499/index.html
-2	/open-h2020/projects/224153/index.html
-3	/open-h2020/projects/195894/index.html
-4	/open-h2020/projects/210597/index.html
-5	/open-h2020/projects/213043/index.html
-6	/open-h2020/projects/208788/index.html
-7	/open-h2020/projects/194138/index.html
-8	/open-h2020/per-topic/herd/list/index.html
-9	/open-h2020/per-topic/precisions/list/index.html
-10	/open-h2020/per-topic/forestall/list/index.html

Opendata, web and dolomites

DIABETESMART

The first Clinically Validated AI-powered Diabetes Assistant

Total Cost €

EC-Contrib. €

Partnership

Views

DIABETESMART project word cloud

Explore the words cloud of the DIABETESMART project. It provides you a very rough idea of what is the project "DIABETESMART" about.

2017 75 2021 diagnosed mission stat clinical complications 137 health shown foresee care chronic 4 outperforms cagr diabetesmart powered 18m 2040 market physician glucose 415 26 642 11 app corporates individuals 2045 platform danish integrate mobile lifestyle globally 12 diabetes forecast team sugar live prevalence employees 2016 potentially device start least life fatal clinically europes 25 intelligent pioneer million ai phone self normal daily class company benefit cumulative 2015 28 estimate revenues founded obtain 10b insights bellow mellitus patient hedia 69 2022 profits blood thousand artificial improvement country recommendations children validated 66 medical 28b people mdr context iia 19 disease provides 200 81 time wearable compliant 2026 easier

Project "DIABETESMART" data sheet

The following table provides information about the project.

Coordinator	HEDIA IVS Organization address address: OLE MAALOES VEJ 3 city: KOBENHAVN postcode: 2200 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Denmark [DK]
Total cost	71˙429 €
EC max contribution	50˙000 € (70%)
Programme	1. H2020-EU.3. (PRIORITY 'Societal challenges) 2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs) 3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
Code Call	H2020-SMEInst-2018-2020-1
Funding Scheme	SME-1
Starting year	2019
Duration (year-month-day)	from 2019-05-01 to 2019-08-31

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	HEDIA IVS HEDIA IVS Organization address address: OLE MAALOES VEJ 3 city: KOBENHAVN postcode: 2200 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	DK (KOBENHAVN)	coordinator	50˙000.00

Map

Project objective

Diabetes mellitus, a common chronic disease that is associated with high blood glucose (also called blood sugar) can lead to potentially fatal health complications. Globally, 415 million people were diagnosed with diabetes in 2015, estimated to reach 642 million by 2040. In Europe disease prevalence is high, 66 million people were diagnosed in 2017, estimate to reach 81 million people by 2045, with 28,200 children (bellow 19 years old) diagnosed each year. Diabetes requires long-life care management from a physician care team and patient daily self-management. Improvement of diabetes self-care was shown when people with diabetes used mobile phone application. Yet, the challenge is to identify a clinical relevant App between the thousand diabetes management applications available in the market. Hedia, a Danish pioneer start-up company was founded with the mission to make life easier for people with diabetes. Based on the current challenges, we have developed a mobile platform for the daily diabetes management that outperforms the current stat-of-the-art: clinically validated Class IIA compliant to Europes’s new MDR; an artificial intelligent powered that provides tailored recommendations based on the individuals lifestyle and country context; integrate the user’s blood medical device and wearable of choice and other advanced features that enable people with diabetes live a normal life. DIABETESMART project targets the diabetes care market, which has an estimate value of €69.10B in 2016, forecast to reach €137.28B by 2022 with a 12.4% CAGR (2016-2022). We aim to offer DIABETESMART to corporates -who will obtain further revenues of €18M per year- and to people with diabetes who will benefit from real-time clinically meaningful insights based on AI by 2021. We foresee to reach revenues of €26.6 million with €75.1 million in cumulative profits and increase our team to at least 25 employees (from current 11) by 2026.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "DIABETESMART" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "DIABETESMART" are provided by the European Opendata Portal: CORDIS opendata.